Evidence map›Paper›PMID 27941893›Full record

ArticleScientific reports2016

EnhancerPred: a predictor for discovering enhancers based on the combination and selection of multiple features.

Cangzhi Jia, Wenying He

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. AttnW2V-Enhancer: Leveraging attention and Word2Vec for enhanced enhancer prediction.Computational and structural biotechnology journal · 2025
    Article
  10. Article
  11. Transformers and large language models in healthcare: A review.Artificial intelligence in medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cangzhi JiaDepartment of Mathematics, Dalian Maritime University, No. 1 Linghai Road, Dalian 116026, China.
Wenying HeDepartment of Mathematics, Dalian Maritime University, No. 1 Linghai Road, Dalian 116026, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancers are cis elements that play an important role in regulating gene expression by enhancing it. Recent study of modifications revealed that enhancers are a large group of functional elements with many different subgroups, which have different biological activities and regulatory effects on target genes. As powerful auxiliary tools, several computational methods have been proposed to distinguish enhancers from other regulatory elements, but only one method has been considered to clustering them into subgroups. In this study, we developed a predictor (called EnhancerPred) to distinguish between enhancers and nonenhancers and to determine enhancers' strength. A two-step wrapper-based feature selection method was applied in high dimension feature vector from bi-profile Bayes and pseudo-nucleotide composition. Finally, the combination of 104 features from bi-profile Bayes, 1 feature from nucleotide composition and 9 features from pseudo-nucleotide composition yielded the best performance for identifying enhancers and nonenhancers, with overall Acc of 77.39%. The combination of 89 features from bi-profile Bayes and 10 features from pseudo-nucleotide composition yielded the best performance for identifying strong and weak enhancers, with overall Acc of 68.19%. The process and steps of feature optimization illustrated that it is necessary to construct a particular model for identifying strong enhancers and weak enhancers.

Identifiers

PMID27941893
PMCPMC5150536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.